Regulatory Roulette: Playing In Today’s Skin-Care Market A Gamble

 
• By Ryan Nelson

Recent FDA warning letters to skin-care firms raise questions about the regulatory risks companies must assume to compete effectively in today’s marketplace. Former FDAer and EAS Senior Adviser John Bailey discusses the strategic decision before personal-care companies as they develop their marketing and the potential consequences of using structure/function claims.

In the current regulatory climate for cosmetics, firms must weigh enforcement risks against potential competitive benefits when crafting product claims, which at times can be a roll of the dice.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight